Evidence map›Paper›PMID 35321694›Full record

ArticleBMC surgery2022

Primary duodenal papilla lymphoma producing obstructive jaundice: a case report.

Jicai Wang, Jiantao Han, Hanbing Xu, Sheng Tai, Xingwang Xie

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jicai WangDepartment of Hepatopancreatobiliary, Thyroid and Vascular Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), No. 241 Pengliuyang Road, Wuchang, Wuhan, 430060, Hubei, China. wangjicai0927@hotmail.com.ORCID http://orcid.org/0000-0001-7980-4412
Jiantao HanDepartment of Hepatopancreatobiliary, Thyroid and Vascular Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), No. 241 Pengliuyang Road, Wuchang, Wuhan, 430060, Hubei, China.
Hanbing XuDepartment of Hepatopancreatobiliary, Thyroid and Vascular Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), No. 241 Pengliuyang Road, Wuchang, Wuhan, 430060, Hubei, China.
Sheng TaiDepartment of Hepatic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 XueFu Avenue, Harbin, 150086, Heilongjiang, China.
Xingwang XieDepartment of Hepatopancreatobiliary, Thyroid and Vascular Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), No. 241 Pengliuyang Road, Wuchang, Wuhan, 430060, Hubei, China.
Tongren Hospital · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObstructive jaundice caused by primary duodenal lymphoma is a rare disease. CASE PRESENTATION: We reported a 59-year-old man who underwent endoscopic ultrasonography for obstructive jaundice and found a duodenal papilla tumor. Light microscopy revealed a non-Hodgkin's lymphoma. Immunohistochemical staining showed that the tumor was aggressive B-cell lymphoma. We carried out molecular targeted therapy combined with CHOP regimen chemotherapy.

conclusionSurgery plays an important role in resolving obstructive jaundice when accurate histological diagnosis cannot be made. After diagnosis, chemotherapy should play a central role in treatment.

Indexed as

Duodenal NeoplasmsJaundice, ObstructiveLymphomaDuodenumHumansMaleMiddle AgedTomography, X-Ray ComputedDuodenal papillaDuodenumJaundiceLymphoma

Identifiers

PMID35321694
PMCPMC8944164
OpenAlexW4220843535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.